Procter & Gamble is looking for new approaches and technologies that can help them to address key business challenges/opportunities. The following innovation brief(s) will provide a high-level overview of specific business goals and needs, as well as a high-level overview of what they are looking for in a solution.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
Trond Undheim, Program Director, MIT Startup Exchange
Procter & Gamble is looking for new approaches and technologies that can help them to address their broad range of sustainability challenges/opportunities. The following innovation brief(s) will provide a high-level overview of specific business goals and needs, as well as a high-level overview of what they are looking for in a solution.
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Nan-Wei Gong, Cofounder & CEO, figur8
Natan Linder, Founder, Tulip
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Panel Discussion
Panelists:
Moderator: Trond Undheim, Ph.D., Lead, MIT Startup Exchange, MIT ILP